Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
20.97
-0.21 (-0.99%)
At close: Dec 5, 2025, 4:00 PM EST
20.80
-0.17 (-0.81%)
After-hours: Dec 5, 2025, 7:43 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $14.58 billion as of December 5, 2025. Its market cap has increased by 79.52% in one year.
Market Cap
14.58B
Enterprise Value
10.30B
1-Year Change
79.52%
Ranking
Category
Stock Price
$20.97
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $14.58B, an increase of 2,634.37%. That is a compound annual growth rate of 94.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 14.73B | 71.05% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |